Study of CTS-1027 in Combination With Pegylated Interferon and Ribavirin in Hepatitis C Virus (HCV) Null-Responders
Public ClinicalTrials.gov record NCT01051921. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label Trial of Pegylated Interferon Plus Ribavirin in Combination With CTS-1027 in HCV Null-Responders
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine if the combination treatment of CTS-1027, pegylated interferon and ribavirin can improve the response rates in HCV patients who did not previously respond to pegylated interferon and ribavirin therapy.
Study identification
- NCT ID
- NCT01051921
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 67 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2009
- Primary completion
- Oct 31, 2011
- Completion
- Nov 30, 2011
- Last update posted
- Apr 15, 2012
2010 – 2011
United States locations
- U.S. sites
- 14
- U.S. states
- 11
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Scripps Clinic | La Jolla | California | 92037 | — |
| VA Medical Center, San Diego | San Diego | California | 92161 | — |
| University of Colorado Health Science Center | Denver | Colorado | 80262 | — |
| South Denver Gastroenterology | Englewood | Colorado | 80113 | — |
| Digestive Healthcare of Georgia | Atlanta | Georgia | 30309 | — |
| Tulane University Health Sciences Center | New Orleans | Louisiana | 70112 | — |
| Henry Ford Medical Center-Columbus | Novi | Michigan | 48377 | — |
| MN Clinical Research Center | Plymouth | Minnesota | 55446 | — |
| St. Louis University | St Louis | Missouri | 63104 | — |
| Consultants of Clinical Research, Ohio GI and Liver Institute | Cincinnati | Ohio | 45219 | — |
| Advanced Liver Therapies - Baylor College of Medicine | Houston | Texas | 77030 | — |
| VA Medical Center, Houston | Houston | Texas | 77030 | — |
| University of Utah Health Science Center | Salt Lake City | Utah | 84132 | — |
| Liver Institute of Virginia | Newport News | Virginia | 23602 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01051921, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 15, 2012 · Synced Sep 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01051921 live on ClinicalTrials.gov.